Professor Keller is an expert on marketing management, branding, and brand equity. His research focuses on improving marketing strategies through an understanding of consumer behavior, as well as on the design, implementation, and evaluation of integrated marketing communication programs. Professor Keller has served as brand advisor to a number of large corporations, including Accenture, American Express, Disney, Ford, Intel, Levi-Strauss, L.L. Bean, Nike, Procter & Gamble, and Samsung. He has published over 120 papers in peer-reviewed journals such as the Journal of Marketing, the Journal of Marketing Research, and the Journal of Consumer Research. He also authored the widely used textbooks Marketing Management (with Philip Kotler) and Strategic Brand Management. Professor Keller has received numerous awards for his research accomplishments, and has conducted marketing seminars for executives in a variety of forums. He previously held faculty positions at the University of California, Berkeley; Stanford University; and the University of North Carolina at Chapel Hill.

A former chief economist at the Federal Communications Commission (FCC), Professor Rogerson focuses his research on applied microeconomic theory, industrial organization, regulation, cost accounting, telecommunications, and defense procurement. He has been an active participant in media transactions before the FCC, including Comcast/NBCUniversal and News Corp./DirecTV, as well as various rulemaking proceedings. Professor Rogerson was also the FCC’s senior economist, supervising its economic analyses of the Comcast/Time Warner Cable, AT&T/DirecTV, and Charter Communications/Time Warner Cable transactions. He has also served as an economic expert for the US Department of Justice, Federal Trade Commission, and the National Association of Attorneys General in various antitrust cases in the telecommunications, media, and defense industries. Professor Rogerson has published a number of articles and book chapters on topics such as vertical mergers in the video programming and distribution industry, and incentives for investment and innovation as related to the regulation of broadband telecommunications. He is a former editor of Economic Inquiry and Defense and Peace Economics, and a former member of the editorial boards of both the Review of Accounting Studies and The Journal of Industrial Economics. He served two terms as chair of Northwestern University’s Department of Economics, and currently holds several leadership roles at Northwestern, including research director of the Program on Antitrust Economics and Competition Policy at the Searle Center on Law, Regulation, and Economic Growth; director of the Center for Business Institutions; and co-director of the Center for the Study of Industrial Organization.

Professor Haas-Wilson is an expert in health care antitrust, including the competitive effects of hospital mergers and commercial health insurer mergers, the effects of vertical consolidation in health care markets, and the implications of physician networks on competition in the health care industry. She recently testified in Federal District Court in Idaho on behalf of plaintiffs, in an antitrust lawsuit alleging competitive harm from St. Luke’s Health System’s acquisition of a large independent physician practice. She has served as a consultant on antitrust issues to the Federal Trade Commission, the Massachusetts Attorney General, the California Department of Corporations, and numerous private entities. She also testified on behalf of the Federal Trade Commission in the matter of Evanston Northwestern Healthcare Corporation. Professor Haas-Wilson is the author of Managed Care and Monopoly Power: The Antitrust Challenge and coeditor of Uncertain Times: Kenneth Arrow and the Changing Economics of Health Care. Her research has appeared in the Journal of Political Economy, the Journal of Economic Perspectives, the Journal of Law and Economics, the Review of Economics and Statistics, and the Journal of Health Economics, among others.

Dr. Rothman specializes in the economic analysis of antitrust and competition issues. He is retained by private parties to present analyses to the US Department of Justice (DOJ) and the US Federal Trade Commission (FTC). He is also retained by and has testified for the FTC as an expert witness in merger litigation. In addition to his merger work, Dr. Rothman has worked on multiple joint conduct and unilateral conduct matters.

Dr. Rothman is a senior editor of the Antitrust Law Journal. He has published research in outlets including Antitrust Law Journal, The Antitrust Source, Journal of Health Economics, Journal of Competition Law & Economics, and Concurrences: Competition Law Journal. Dr. Rothman has taught a course on the economics of merger analysis in the economics department at Harvard University. Prior to joining Analysis Group, he was an assistant professor at Columbia University.

Professor Pindyck is a leading industrial organization economist and testifying witness in the areas of antitrust and intellectual property. His research and writing have covered topics in microeconomics and industrial organization, the behavior of resource and commodity markets, financial markets, and econometric modeling and forecasting. His recent work in economics and finance has examined the determinants of market structure and market power, the dynamics of commodity spot and futures markets, criteria for investing in risky projects, the role of R&D, and the value of patents. He has received many academic honors, including several awards for outstanding teaching, and holds senior editorial positions with a number of publications. Professor Pindyck has consulted to dozens of public and private organizations, including the Federal Trade Commission, IBM, and AT&T, and has been deposed and/or testified in over a dozen cases in diverse industries such as food, energy, software, medical devices, and airlines. He has worked with Analysis Group on many of these cases, including the Lotus v. Borland litigation, in which Professor Pindyck used econometric modeling techniques to identify the economic value of various attributes and isolated the value of the infringing features. He also worked with Analysis Group in a major litigation matter involving price-fixing allegations, in which he examined allegations of accumulation of buying power and the resulting effects on negotiations with suppliers.

Ms. Guérin is an economist who specializes in the application of statistics and econometrics to health economics and outcomes research (HEOR) and epidemiology. Her areas of expertise include retrospective database analyses such as medical claims, electronic health records, and clinical trial data; economic modeling, such as cost-effectiveness and budget impact models; and design of chart review studies, surveys, and other prospective studies. She has participated in the development of large clinical data registries and in the design of real-world evidence (RWE) studies to support regulatory submissions. Ms. Guérin has broad research and analytical experience in areas such as comparative effectiveness and cost effectiveness, development of prediction algorithms, assessment of disease prevalence and incidence, evaluation of burden of illness, productivity loss, treatment patterns, analysis of patient-reported outcomes (PROs), safety/tolerability analyses, discrete choice experiments, and patient experience studies. She has also supported many pharmaceutical companies in the development of HEOR planning and RWE generation plans. Ms. Guérin has conducted health care research across many therapeutic areas, including oncology, hematology, dermatology, gastroenterology, rheumatology, neurology, psychiatry, endocrinology, cardiology and circulatory diseases, and respiratory diseases. She publishes frequently and is the coauthor of over 100 research papers published in numerous peer-reviewed journals and presented at a variety of scientific conferences.

Dr. Cain is an expert in securities litigation, corporate disclosures, M&A litigation, private equity, valuation, insider trading, and corporate governance. He has provided economic analysis, consulting, and expert witness testimony on a variety of finance topics for investigations, settlement negotiations, and trials. He has estimated event studies and trading profits in relation to allegations of insider trading, improper trading behavior, corporate misrepresentations and disclosures, and unregistered stock sales on behalf of the US Securities and Exchange Commission (SEC), US Department of Justice (DOJ), Commodity Futures Trading Commission (CFTC), and other clients. Dr. Cain worked for several years at the SEC, where he was an advisor to Commissioner Jackson and a financial economist in the Office of Litigation Economics. Prior to joining the SEC, Dr. Cain was an assistant professor of finance at the University of Notre Dame Mendoza College of Business. He has published research in numerous journals on topics that include investment banking and fairness opinion valuations, merger contracts and terminations, corporate governance and shareholder activism, hostile takeovers, earnout clauses, merger-related litigation, and management buyouts. Dr. Cain’s research has been cited in forums such as the US Chamber Institute for Legal Reform, amicus briefs to the US Supreme Court, trial verdicts of the Supreme Court of the State of New York and the Delaware Chancery Court, and The International Comparative Legal Guide to Mergers and Acquisitions. His research has also been highlighted in media outlets such as The Wall Street Journal, The New York Times, the Financial Times, and Forbes.

Professor Kinch, a drug development expert specializing in cancer, immunological, and infectious diseases, focuses on combining cutting-edge science and entrepreneurship to improve public health. At Washington University in St. Louis, Professor Kinch founded and directs the Center for Research Innovation in Biotechnology (CRIB), which assesses trends that guide the research and development of novel medicines. He also helped create the Center for Drug Discovery (CDD) to identify and underwrite the university’s most promising drug discovery projects. Professor Kinch has been issued more than a dozen US patents, published more than 100 patent applications, and written several books and book chapters on the commercialization of biopharmaceutical innovation, as well as other aspects of drug development. He has published widely in peer-reviewed journals, including Drug Discovery Today, Science, Cell Chemical Biology, and Biotechnology Law Report, and his research has been profiled in media outlets such as The Wall Street Journal, NPR, CBS News, and The New York Times. Before joining Washington University, he was the managing director of the Yale Center for Molecular Discovery. He has also taught at Johns Hopkins University and Purdue University, and held senior research positions at Functional Genetics and MedImmune. Professor Kinch serves on the board of the American Cancer Society and on scientific advisory boards (SABs) for several biopharmaceutical companies.

Professor Rossiter is an expert in health economics who has testified or served as an expert in the following areas: competition in the financing and delivery of health services; reimbursement economics, especially for Medicare, Medicare Advantage, and Medicaid; managed care organizations; prescription medicines; survey research; and health information analytics. Professor Rossiter is the former secretary of health and human resources for the Commonwealth of Virginia. In that role, he was responsible for over 15,000 employees in 13 agencies (including 10 state mental hospitals), brought major information technology projects in the Secretariat to national prominence, and made major reforms in Virginia Medicaid. He also served as deputy for policy to the Administrator of the Centers for Medicare and Medicaid Services (CMS). As deputy, he created and directed a new payment system for US hospitals under Medicare, was responsible for the CMS strategic plan, and formulated all agency policy initiatives through the federal legislative process.

Prior to joining the William & Mary faculty, Professor Rossiter was a professor of health administration at Virginia Commonwealth University. He served on the board of regents of the National Library of Medicine, National Institutes of Health; on the board of directors of AcademyHealth; and as chair of the board of directors of the Coalition for Health Services Research, the lobbying arm of AcademyHealth, during the passage of the Affordable Care Act. He has also served on numerous advisory groups, including the National Advisory Council for Healthcare Research and Quality, and is currently a trustee and chair of the Williamsburg Health Foundation. Professor Rossiter is the author or editor of 15 books, and the author of over 50 journal articles on health economics and the role of competition in the financing and delivery of health services.

Mr. Darling consults to clients and provides expert testimony to address litigation, strategy, regulatory, and policy questions in a wide range of antitrust and competition, class certification, health care, energy, and environmental matters. He has submitted and supported expert testimony before US district and appellate courts, state utility commissions, siting boards, and federal agencies. He has also assisted clients with responses to government investigations and presented findings before US Attorneys’ Offices, state attorneys general, and the US Drug Enforcement Administration.

In the areas of health care and antitrust, Mr. Darling has extensive experience supporting clients on issues related to discovery and data production, class certification, patent infringement, market definition and market power, and competitive effects in pharmaceutical and life sciences matters involving patent infringement issues, reverse payment settlements, and product hop allegations. He has also designed and implemented customized suspicious order monitoring (SOM) and loss prevention programs for controlled substances, and has experience in False Claims Act and Anti-Kickback Statute litigation cases, including analyses of causation and damages calculations.

Mr. Darling is also an expert on electricity, oil, and natural gas pricing, markets, and infrastructure. His consulting work on behalf of utilities, state and regional organizations, and global companies includes projects related to cost/benefit analyses of new plant construction and retirements; ratepayer and bill impacts; environmental effects of emissions and pollution controls; economic impacts of energy projects, mergers, and policies; natural gas, biomass, and other market studies; and climate change matters including decarbonization policy proposals and quantification of the impacts of greenhouse gas emissions. He has conducted and overseen numerous economic and bill impact assessments in support of projects and policy proposals, ranging from new power plants and transportation facilities to electric, petroleum, and natural gas transmission infrastructure.

Ms. Hitscherich specializes in corporate acquisitions, leveraged buyouts, exclusive sales and divestitures, takeover defenses, and restructurings. She has served as an expert witness in several complex securities litigations, including matters involving deal structure, valuation, due diligence, custom and usage in the finance industry, and financing alternatives.

Ms. Hitscherich has extensive experience in investment banking and corporate law practice, including as a managing director in mergers and acquisitions with Banc of America Securities, where she was secretary of the Fairness Opinion Review Committee; vice president in mergers and acquisitions with J.P. Morgan & Co., where she was a founding member of the takeover defense team and a senior member of the acquisitions fairness Advisory Review Committee; and as a mergers and acquisitions attorney with Skadden, Arps, Slate, Meagher & Flom.

Dr. Royer applies a broad range of quantitative tools to address client needs in data science, statistics, HEOR, finance, intellectual property, competition policy, and antitrust cases in the United States, Canada, and the EU. His recent work includes predicting the potential future onset of rare or undiagnosed conditions with machine learning models; predicting whether patents would be considered essential to technological standards if challenged in courts; valuing patents in the communications industry; evaluating damages related to product defects; analyzing investment guidelines in securities lending suits; addressing allegations of monopolization in major antitrust cases involving high tech firms; and supporting many academic experts on mutual fund market timing and excess fee cases. In addition, Dr. Royer has conducted extensive academic research and coauthored books and papers on topics such as using new AI advances in HEOR; predicting treatment resistance in tuberculosis, using machine learning algorithms in propensity score models; measuring the impact of ESO backdating on shareholders’ wealth; analyzing mutual fund pricing; analyzing antitrust limit pricing; valuing private investments for hospitals in Canada; determining the impact of hypertension therapies on mortality; and comparing unemployment compensation in different countries.

Professor Reibstein’s research focuses on competitive marketing strategies, metrics, and product line decisions, among other topics. He has provided marketing management education and consulting research to companies in the consumer goods, pharmaceutical, and oil and gas industries, among others. His consulting activities have included numerous applications of conjoint analysis and other survey techniques in engagements spanning a wide range of products. Professor Reibstein has submitted expert reports and provided testimony on marketing and marketing research in several litigation matters, including analyses of smartphone features in a patent dispute, health claims in a false advertising dispute, and pharmaceutical detailing in a co-marketing dispute.

His recent work includes assessing strategies to address competitors’ reactions to marketing actions and developing metrics that link marketing decisions to financial consequences, which was published in his book, Marketing Metrics: The Definitive Guide to Measuring Marketing Performance. Professor Reibstein is also the author or coauthor of numerous books and chapters in books on subjects including competitive marketing strategy, global branding, and marketing performance measurement. Professor Reibstein has also written several papers on conjoint analysis and its validity and reliability. His research has been published in leading academic journals, including Marketing Science, the Journal of Marketing Research, and the International Journal of Research in Marketing.  

Professor Reibstein has been honored with more than 30 teaching and publishing awards, including the John S. Day Distinguished Alumni Academic Service Award from Purdue University’s Krannert School of Management. He has served as the chairman of the American Marketing Association board of directors and as the executive director of the Marketing Science Institute.

Professor Carlson specializes in the marketing management implications of consumer decision-making processes, including the development of brand preferences and the influence of emerging preferences on the decision making process. Though much of Professor Carlson's research explores consumer decision making, he also studies how voters, jurors, and managers make decisions. Over the last 20 years, he has run thousands of surveys, sampling U.S. and international populations.

Professor Carlson has served as an expert in evaluating a survey in a class action matter, consulted on a high profile class action settlement involving consumer deception, and testified before the SEC in an equity trust matter. Professor Carlson's published research can be found in top marketing, psychology, and management journals. He is also the coauthor of Contemporary Brand Management. He blogs for Psychology Today and Forbes, and maintains an active Twitter account (@ProfKurt). While teaching at Georgetown University between 2009 and 2017, Professor Carlson was director of the Georgetown Institute for Consumer Research and co-director of the McDonough School of Business Behavioral Research Lab, and he received the MSB Dean's Distinguished Faculty Research Award and the Decision Analysis Society's Publication Award.

Ms. Kindler has worked on a variety of engagements, including intellectual property (IP) disputes, contract disputes, litigation matters related to securities and finance, false advertising allegations, and antitrust matters. In litigation matters, she has testified in deposition and at trial, and assisted in all phases of the litigation process, including discovery, expert reports, deposition, and trial preparation. In patent infringement matters, Ms. Kindler has analyzed claimed lost sales, claimed lost profits, and claimed reasonable royalty damages. In antitrust matters, she has assessed the competitive consequences of mergers, analyzed the competitive behavior of market participants, and estimated the impact of market power. Her work has also included the development of complex damages models, the analysis of statistical data, and the analysis of stock price movements. Ms. Kindler has been recognized as among the top economic experts for IP matters by Intellectual Asset Management (IAM) in the IAM Patent 1000, which identifies leading patent professionals around the globe. Prior to joining Analysis Group, she held positions with two economics consulting firms.

Professor Klausner teaches courses on corporate law, corporate governance, business transactions, and regulation of financial institutions. In recent years, most of his writing has been on corporate governance. He maintains a database on securities class actions and SEC enforcement actions, and has written papers and blog posts based on that database. In addition, Professor Klausner is currently writing a book and producing an online course called Deals: The Economic Foundations of Business Transactions.

Before beginning his academic career, Professor Klausner practiced law in Washington, DC, and Hong Kong. He was a White House fellow from 1989 to 1990, a law clerk for Judge David Bazelon on the United States Court of Appeals for the District of Columbia Circuit in 1981-82, and a law clerk for Justice William Brennan on the United States Supreme Court.

Professor Hochberg specializes in entrepreneurship, innovation, venture capital, and private equity, focusing on venture capital networks, entrepreneurial finance, seed accelerators, and corporate governance and compensation. Her research covers topics such as venture capital investment performance, the effects of networks and syndication on venture capital firms, and investment selection. Professor Hochberg has also explored the private equity investment choices of pension funds and other institutional investors, as well as broad-based option compensation in firms. She is the managing director of the Seed Accelerator Rankings Project, which publishes annual rankings of accelerator programs in the US. Prior to joining the Rice faculty, she held positions at the Kellogg School of Management at Northwestern University and the Samuel Curtis Johnson Graduate School of Management at Cornell University. She has taught courses on entrepreneurial finance and health care innovation, and has served as an associate editor of several finance journals, including the Journal of Empirical Finance and the Journal of Banking and Finance. Professor Hochberg is a recipient of the Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship, and a research associate at the National Bureau of Economic Research. Prior to joining academia, she was a software engineer at both established and startup technology companies, and co-founded a startup. Professor Hochberg is an active angel investor and advisor to startups, and a Landmark Fellow with Landmark Partners, a large private equity investor in secondary markets. She is a co-founder of Flywheel Innovation, a corporate innovation advisory firm.

Mr. Davis specializes in applying financial economics and data analysis to major litigation matters, with a focus on agricultural markets and pharmaceutical products. He has experience managing case teams, supporting academic affiliates and industry experts, and assisting clients through all phases of complex business litigation, including fact discovery, class certification, merits, trial, and settlement. Mr. Davis’s agricultural experience includes antitrust matters involving allegations of market power in animal protein markets, matters involving the presence of genetically modified products in US grain supplies, and matters involving international trade in agricultural products. His pharmaceutical work includes antitrust matters involving allegations of delayed generic entry, False Claims Act matters involving allegations related to the promotion of pharmaceuticals, and disputes pertaining to the commercial reasonableness of firm conduct.

Mr. Davis also has experience conducting economic research across a variety of industries, including financial services, agriculture, and pharmaceuticals, and analyzing issues related to commodity markets, futures prices, intellectual property and patents, industrial organization and antitrust law, and financial market infrastructure. He is a CFA charterholder. 

Dr. Schatzki has a broad range of expertise in energy, environment, finance, and competition matters. He supports clients in a range of contexts, including strategic and financial advice, policy analysis, regulatory and rulemaking proceedings, and litigation.

Dr. Schatzki has deep experience in electricity, natural gas, petroleum, and renewable energy. His expertise in the electricity sector includes wholesale energy and capacity market design; utility regulation and ratemaking; economic impact analysis of new market rules, regulations, and generation and transmission investments; contract analysis and disputes; financial valuation; and options analysis. Dr. Schatzki has testified before US state and federal, as well as Canadian provincial, regulatory commissions. He has supported the analysis of alleged market manipulation and damages in high-profile litigations such as FERC v. Barclays and lawsuits following the California electricity crisis.

Dr. Schatzki works extensively on environmental economics, policy, and regulation. Recently, he has focused on the intersection of climate policy and energy markets, and disputes involving water resources and environmental contamination. His research has been published in distinguished energy- and environment-related publications, and he has provided research for prominent organizations such as the Electric Power Research Institute, the Edison Electric Institute, and the Federal Energy Regulatory Commission.

In finance and competition matters, Dr. Schatzki has worked with clients on litigation and non-litigation projects in many sectors, including energy, financial instruments, foreign exchange, insurance, airlines, and retail products. 

Dr. Koehn specializes in applied microeconomics and finance. He has performed research and given economic testimony in antitrust, regulatory, tax, and other business litigation matters. The author of several publications on topics such as banking and finance, energy economics, and real estate, Dr. Koehn is a former adjunct associate professor of finance at the University of California, Irvine Graduate School of Management.

Mr. Case is an institutional investment expert with significant expertise in the areas of investment governance, asset allocation, portfolio design and implementation, and portfolio analysis and reporting. As a former institutional investment consultant, he worked with a wide range of global clients, including insurers, health care organizations, corporate and public plan sponsors, family offices, and other large asset pools. Mr. Case was a partner at Mercer Investment Consulting, a practice leader at Evaluation Associates, and a senior consultant at Rogerscasey. He led client service teams for large clients, including defined-benefit and defined-contribution plans, insurers and mutual fund families, and registered investment advisors and foundations. As an expert, Mr. Case has evaluated various process-related issues, including the process used to monitor an ERISA plan’s investment advisor and delegated fiduciary. He previously worked as an investment analyst for AT&T’s pension investment team, oversaw the sub-advisory and pension assets of AXA Equitable Life, and managed the strategic relationship team at Putnam Investments. He is a CFA charterholder.

Ms. Kirk Fair has extensive experience leading the development of economic and market analyses, assessing class certification and damages, evaluating consumer behavior, and testifying in a wide range of matters in the US, Canada, and Europe. She has been deeply involved in merger investigations and major antitrust litigation, as well as intellectual property (IP), false advertising, and tax matters. She also is a founder of the Analysis Group’s Surveys & Experimental Studies practice.

Ms. Kirk Fair specializes in evaluating competition and substitution patterns to examine potential competitive effects in mergers and “but-for” outcomes in antitrust litigation. She has significant analytical and testifying experience in cartel matters, notably in a number of prominent cases in the technology, consumer products, and financial services industries. She also has evaluated competition, pricing, and outputs in connection with merger investigations in the US, Canada, and the EU. In addition to having served as a compliance monitor for several years, she has supported the US Department of Justice (DOJ), the Federal Trade Commission (FTC), and the Canadian Competition Bureau (CCB) in a variety of merger investigations.

Ms. Kirk Fair also has particular expertise in the development, administration, and analysis of consumer surveys for use in antitrust, false advertising, and IP matters, as well as merger reviews and strategy cases. She has testified in arbitration, deposition, and trial in matters involving the design and implementation of consumer surveys, as well as the evaluation of opposing parties’ surveys and of statistical sampling and analyses. Her work has been used to support and critique damages models and to provide insights into the role of consumer choice in market definition.

Ms. Kirk Fair serves as a Vice-Chair to the American Bar Association (ABA) Antitrust Law Section’s Pricing Conduct Committee. She has received numerous awards for her accomplishments, including the W@ “40 in Their 40s: Notable Women Competition Professionals” and the Concurrences Antitrust Writing Award for her coauthored article “The Tyranny of Market Shares: Incorporating Survey-Based Evidence into Merger Analysis” (Corporate Disputes).

Read Rebecca's profile

Professor Riddiough is best known for his work on real options, mortgage pricing and strategy, REITs, and land use regulation. He has served as an expert in numerous real estate-related matters, in which he has testified on appraisal and the value of distressed mortgages. Professor Riddiough has consulted to numerous organizations, including the US Department of Housing and Urban Development, GMAC, Wells Fargo, Coldwell Banker Commercial, The Equitable Life Assurance Society, and the State of Wisconsin Investment Board. He has published more than 40 scholarly articles. He has served on the boards of directors of several organizations, including ArCap REIT, EquiBase Capital Partners, and the American Real Estate and Urban Economics Association. Professor Riddiough is the recipient of best dissertation and best paper awards in real estate economics, and is a fellow at the Real Estate Research Institute and a past fellow at the Homer Hoyt Institute. He teaches courses in real estate finance, real estate capital markets, and microeconomics.

Mr. Deal leads the economic analyses in the Menlo Park, California office and helps coordinate the firm’s Insurance practice. He combines an economics and risk analysis background with many years of experience in economic, litigation, and management consulting. He serves as a testifying and consulting expert on a wide variety of matters, often involving economic and statistical analysis of large datasets. His work as an expert has covered a variety of practice areas, including antitrust, economic damages, class action matters, and business valuation. Mr. Deal’s experience includes work in health care, insurance, finance, technology, and many other industries. He has coauthored a number of book chapters and studies, including The Economic Effects of Federal Participation in Terrorism Risk with R. Glenn Hubbard, an Analysis Group academic affiliate, former chair of the President’s Council of Economic Advisers, and former dean of the Columbia Business School.

Professor Savitz focuses his epidemiological research on a wide range of public health issues, from the health effects of environmental agents in the workplace and community to a wide range of reproductive health outcomes. He has served as principal investigator on more than three dozen public health studies, including as one of three epidemiologists to evaluate the probable causal link between exposure to perfluorooctanoic acid and the development of certain diseases. Professor Savitz submitted an expert report on behalf of the plaintiffs at the class certification stage of a litigation matter and has consulted on a wide range of issues related to both environmental and reproductive epidemiology. He is the author of more than 300 journal articles and has edited or authored three books, including Interpreting Epidemiologic Evidence: Connecting Research to Applications. Professor Savitz has served as the editor of Epidemiology and the American Journal of Epidemiology, a member of the Epidemiology and Disease Control Study Section of the National Institutes of Health, president of the Society for Epidemiologic Research and the Society for Pediatric and Perinatal Epidemiologic Research, and North American regional councilor for the International Epidemiological Association. He is a member of the National Academy of Medicine and served as vice president for research at Brown University.

Dr. Signorovitch advises life sciences companies on data analytics for business critical research and decision making. He has broad experience leading the strategic development and implementation of analytics across the product life cycle, from early-phase clinical studies to market access and real-world evidence generation. Dr. Signorovitch’s practice areas span trial design, multi-stakeholder collaborations, natural history studies, regulatory interactions, health economic modeling, global reimbursement submissions, policy evaluation, real-world evidence development, individualized medicine, predictive analytics, and due diligence for acquisitions. He has particular expertise in developing and applying new methodologies to address health care research challenges, and in designing analytics platforms to enhance collaborative research and decision making. Dr. Signorovitch’s work has been used to inform clinical regulators and health care payers in US and global markets, published in peer-reviewed journals, and presented at clinical and economic research conferences. Prior to joining Analysis Group, Dr. Signorovitch was a research fellow at the Harvard-MIT Division of Health Sciences and Technology.

Professor Schoar is an expert in corporate finance, entrepreneurship, and organizational economics. Her research interests span from entrepreneurial finance to household finance and financial intermediation. Her research examines returns and capital flows in the venture capital industry, the financing of small and medium-sized enterprises and startup firms, and the role of consumer financial markets. Professor Schoar has served as an expert witness in cases involving commercial litigation and financial services. She is co-organizer of the Corporate Finance Working Group at the National Bureau of Economic Research, a former member of the Consumer Financial Protection Bureau’s Academic Research Council, and co-founder and scientific director of ideas42, a research lab on behavioral social science. She has published numerous articles and papers and received several awards for her research, including the Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship and the Brattle Group Prize in Corporate Finance for her paper “The Effects of Corporate Diversification on Productivity.” She has served as an associate editor of The Journal of Finance, the American Economic Journal: Applied Economics, and the Journal of Economic Perspectives. Professor Schoar’s work has been featured in The Economist, the Financial Times, The New York Times, and The Wall Street Journal.

Professor Chalmers is an expert in securities issues, including the trading behavior of investors and the pricing of securities. He has undertaken extensive research in municipal bonds, mutual funds, and trading costs, much of which has been published in leading peer-reviewed academic journals, including The Journal of Finance, the Journal of Financial Economics, and The Review of Financial Studies. In the area of mutual funds, his research with Professors Roger Edelen and Greg Kadlec discovered and explained the source of perverse incentives exploited by so-called market timers in their trading of mutual funds. He has also written about stale pricing problems in equity mutual funds and mutual fund transaction costs, and has collaborated with other mutual fund experts, such as Professors Daniel Bergstresser and Peter Tufano, on research analyzing fund performance across fund marketing channels. He also has extensive expertise in municipal bond pricing and valuation issues. Professor Chalmers' research has been cited in reports by the General Accounting Office and in several testimonies provided before the House Financial Services Committee, as well as being widely referenced in major media outlets. He has authored several expert reports and provided testimony before the US District Court of Wisconsin.

Dr. Lehmann specializes in applying microeconomics, econometrics, and statistical methods to complex litigation and government investigations in the areas of antitrust and competition, labor and employment, health care, and commercial damages. She has extensive experience in labor market antitrust matters and has evaluated market definition, market power, class certification, liability, and damages issues in antitrust cases in the pharmaceutical, health care, technology, and consumer products industries. In labor and employment matters, Dr. Lehmann has served as a testifying or consulting expert in matters involving allegations of worker misclassification, violations of wage & hour laws, discrimination, and breach of non-compete agreements. In her work with pharmaceutical and medical device industries, she has analyzed economic, health, and scientific data to assess liability, damages, and causation. She regularly leads teams supporting biostatisticians, epidemiologists, scientists, and regulatory experts in evaluating research and development processes and analyzing clinical trial, laboratory testing, registry, medical claims, and adverse events data in product liability, intellectual property, and breach of contract disputes.

Dr. Lehmann research has been published in the Journal of Economic Literature, The Journal of Human Resources, Labour Economics, Cartel & Joint Conduct Review, Distribution, Cybersecurity Law & Strategy, and Antitrust Report, and her academic work has been cited in leading media outlets, including Scientific American, Forbes, and BBC News. She serves as a vice-chair of the Distribution and Franchising Committee of the American Bar Association (ABA) Antitrust Law Section. Prior to joining Analysis Group, Dr. Lehmann was an assistant professor of economics at the University of Houston, where she taught courses in labor economics and microeconomics.

Dr. Kupiec’s research interests include quantitative financial risk measurement, systemic risk, deposit insurance, and the regulation of banking and financial services. At the American Enterprise Institute, he has authored several studies on systemic risk measurement and related regulations, bank stress testing, and bank regulations that follow financial crisis, including their impact on the wider economy. Dr. Kupiec was an associate director of the Division of Insurance and Research and director of the Center for Financial Research (CFR) at the Federal Deposit Insurance Corporation. In these roles, he oversaw research on bank risk measurement that contributed to the development and implementation of regulatory policies, including the international Basel III framework. He also served as chairman of the Research Task Force of the Basel Committee on Banking Supervision. Dr. Kupiec has worked at the International Monetary Fund, Freddie Mac, and J.P. Morgan, as well as for the Division of Research and Statistics at the Board of Governors of the Federal Reserve System. Prior to entering the financial services industry, Dr. Kupiec was an assistant professor of finance at North Carolina State University. He has published articles in several academic journals, including The Journal of Finance, the Journal of Financial Intermediation, the Journal of Financial Stability, the Journal of Financial Services Research, The Journal of Risk, and the Journal of Investment Management.

Mr. Decter specializes in the application of microeconomics, finance, and data analysis to complex securities and antitrust litigation and business strategy cases, most notably in matters related to residential mortgage-backed securities, collateralized debt obligations and credit default swaps, residential mortgage lending, mortgage reinsurance, commercial insurance, private equity, and payment cards. He has conducted damages analyses, and supported multiple experts in the areas of statistical sampling, loan and securities underwriting, damages, and loss causation.

Mr. Decter's business litigation experience focuses on finance matters in which he has managed large case teams and data sets in working with testifying experts. He supported academic affiliates in their examination of class certification issues related to commonality, predominance, and causation in In re Countrywide Financial Corp. Mortgage Marketing and Sales Practices Litigation, a mortgage marketing matter in which the plaintiff's motion for class certification was denied. Mr. Decter also supported an expert in filing a report on behalf of the defendants in New Jersey Carpenters Vacation Fund et al. v. The Royal Bank of Scotland Group plc et al., a case that marked the first major ruling on class certification among the numerous mortgage-backed securities actions pending in courts across the country at the time. He has also conducted damages analyses and worked with experts in numerous securities, antitrust, and intellectual property cases. Mr. Decter's business strategy engagements related to strategic pricing, portfolio management, and economic cost studies have spanned multiple industries, including pharmaceuticals, telecommunications, information technology, and manufacturing.

Prior to joining Analysis Group, Mr. Decter was a management consultant in the telecommunications industry. He also has several years of telecommunications industry experience in strategic planning, business development, and product management. 

Professor Savoldelli is a finance and investment expert with over 25 years of experience analyzing and advising on a wide range of hedge fund-focused issues, including fund performance, portfolio construction, fund administration, due diligence, capital raising, and asset allocation. He served as a chief investment officer for four different institutions: Optima Fund Management, Merrill Lynch, Swiss Bank Corp. Asset Management, and Chase Manhattan Private Bank. In these roles, he oversaw over $80 billion in assets.

Over the course of his investment career, Professor Savoldelli’s responsibilities included selecting hedge funds for the allocation of investor assets, making asset allocation decisions, managing investment portfolios, developing investment policies, and overseeing investment manager adherence to investment strategy and policy. He has deep experience related to the challenging issues hedge fund managers may face, including those related to fiduciary duty, disclosure, liquidation, side-pockets accounts, and valuation of complex and illiquid assets. Additionally, he is knowledgeable about the roles and responsibilities of hedge fund service providers such as prime brokers, marketers, administrators, and auditors.

At Columbia Business School, Professor Savoldelli teaches a course in the M.B.A. program on the investment strategies employed by hedge funds and best practices for the operational aspects of hedge fund management, including fund administration selection, operational risk evaluation, and leverage risk. In addition, he is a contributing editor on Bloomberg Television, commenting on developments from a hedge fund perspective.

Professor Slottje has deep experience in both academia and economic consulting. An emeritus professor of economics at Southern Methodist University, he has been working in litigation consulting for more than three decades in senior positions with several international firms. He has worked with many leading law firms, testifying at deposition and trial in hundreds of prominent matters.

An economist and a statistician, Professor Slottje is an expert in the fields of labor economics, consumer demand, industrial organization, and statistics and econometrics, allowing him to bring a unique perspective and skill set to his consulting assignments. He has published more than 150 journal articles and more than a dozen books, and has been ranked among the world’s top three scholars in applied econometrics based on his publishing record in the field. Professor Slottje is a member of the American Economic Association, the American Statistical Association, and The Econometric Society.

Professor Kahn’s research interests include brand management and loyalty, consumer choice and decision making, price promotions, and retailing. She has served as an expert witness and testified at deposition in numerous matters. Professor Kahn is the author of Global Brand Power: Leveraging Branding for Long-Term Growth and The Shopping Revolution: How Retailers Succeed in an Era of Endless Disruption Accelerated by COVID-19, and coauthor of Grocery Revolution: The New Focus on the Customer. She has published more than 70 articles in leading academic journals. She is a former area editor of Marketing Science, the Journal of Consumer Research, the Journal of Consumer Psychology, and the Journal of Marketing, and has served on the editorial boards of the Journal of Marketing, the Journal of Marketing Research, Marketing Science, the Journal of Consumer Research, the Journal of Behavioral Decision Making, and Marketing Letters. Prior to joining The Wharton School, Professor Kahn was on the faculty of the UCLA Anderson School of Management. She also served as dean of the Miami Herbert Business School.

Professor Snyder is an industrial organization economist whose research focuses on antitrust policy and enforcement, contracting practices, financial institutions, and law and economics. He has consulted on and served as a testifying expert in numerous high-profile cases, opining on liability, damages, proposed mergers, price-fixing allegations, Hatch-Waxman claims involving pharmaceuticals, monopolization claims, and proposed class certifications of both direct and indirect purchasers. In addition, Professor Snyder has testified before combined US Federal Trade Commission (FTC) and US Department of Justice (DOJ) hearings on competition and intellectual property, and has presented separately before the DOJ’s Antitrust Division, where he worked as an economist earlier in his career, and the FTC. He has been a signatory to amicus briefs submitted to the Supreme Court on various price-fixing and Sherman Act issues.

Professor Snyder has written extensively on topics related to antitrust and policy issues, with his articles appearing in prestigious publications such as The Journal of Law and Economics, the Journal of Comparative Economics, The Antitrust Bulletin, and Contemporary Policy Issues. His work has also been featured in major media outlets, including the Financial Times, The Wall Street Journal, and The New York Times.

Professor Snyder also served as the dean of the Yale School of Management from 2011 to 2019, during which time he enhanced the school’s academic programs and financial standing, and established new master’s programs in the areas of management, entrepreneurship, and executive education. He also founded the Global Network for Advanced Management at Yale University, an international consortium of schools devoted to teaching tomorrow’s business leaders around the world. Prior to joining Yale, Professor Snyder was the dean of the business schools of The University of Chicago, the University of Virginia, and the University of Michigan.

Dr. Mathur specializes in the application of microeconomics, statistics, and econometrics to complex litigation matters, regulatory investigations, and consulting engagements in the areas of antitrust and competition, class certification, intellectual property, and commercial damages. Dr. Mathur has provided expert economic testimony on antitrust, class certification, and damages issues and has testified at depositions and in federal court. She regularly collaborates with academic and industry experts, leads consulting teams, and supports attorneys and other stakeholders in all phases of litigation. She has worked on behalf of the US Department of Justice (DOJ) and the Federal Trade Commission (FTC), and consulted to firms in numerous industries, including technology, media, telecommunications, pharmaceuticals, consumer products, financial services, manufacturing, and chemicals.

Dr. Chan is a practicing internal medicine physician and an economist. His research draws on industrial organization, labor economics, and applied econometric principles to study how technology and information are used in health care, and how they affect productivity and patient care. Dr. Chan’s government service includes roles as entrepreneur in residence in the White House Office of Science and Technology Policy, staff fellow in the Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research, and medical device fellow in the FDA’s Center for Devices and Radiological Health. He has published on health economics and policy in medical and economics journals such as The New England Journal of Medicine, the Journal of Political Economy, Econometrica, and The Quarterly Journal of Economics. Dr. Chan presents frequently at national and international conferences and has received numerous grants and awards, including the National Institutes of Health Director’s High-Risk, High-Reward Early Independence Award, and a Marshall Scholarship. He is a senior fellow at the Stanford Institute for Economic Policy Research and a faculty research fellow at the National Bureau of Economic Research. 

Professor Laby is an expert in securities law, the regulation of investment management, and the fiduciary obligation. He has been retained as a consultant and expert witness, and he has testified both in court and in Securities and Exchange Commission (SEC) administrative proceedings in securities and corporate law matters involving issues such as investment suitability, fiduciary duty, the roles and responsibilities of broker-dealers and investment advisors, and conflict-of-interest transactions in the investment industry. Professor Laby is coauthor of a multi-volume treatise titled The Regulation of Money Managers: Mutual Funds and Advisers. He has published articles on topics such as the regulation of financial services firms, the regulation of retirement advisors, and the regulation of global financial firms in publications such as the Washington Law Review, the Florida Law Review, the Boston University Law Review, the Tulane Law Review, the Review of Banking and Financial Law, and The Business Lawyer. Professor Laby previously served on the board of directors of the Certified Financial Planner Board of Standards, as chairman of the board of trustees of the SEC Historical Society, and as a member of an American Bar Association task force that prepared the fourth edition of the Fund Director’s Guidebook. Prior to joining the Rutgers faculty, Professor Laby served as assistant general counsel at the SEC, where he was responsible for investment management and international matters, and was in private practice.

Professor Scharfstein is a biostatistician with expertise in the design, monitoring, and analysis of randomized clinical trials and observational studies. His research focuses on methods of reporting the results of clinical studies in which missing or censored data, non-compliance, or non-random treatment assignment may have resulted in selection bias. He has testified at deposition and trial in a number of litigation matters involving drug and medical device safety and efficacy in and outside the US. In addition, Professor Scharfstein regularly consults to the pharmaceutical industry, advising on statistical issues related to the regulatory approval of drugs and medical devices. He has served on multiple data safety monitoring boards for clinical trials, including for the National Institute of Allergy and Infectious Diseases. Professor Scharfstein is the principal biostatistician for the Major Extremity Trauma Research Consortium, which conducts multicenter clinical research studies relevant to the treatment and outcomes of orthopedic trauma sustained in the military. Professor Scharfstein is a fellow of the American Statistical Association, a recipient of the ASA’s George W. Snedecor Award for best paper in biometry, and a recipient of the Harvard T.H. Chan School of Public Health Department of Biostatistics’ Lagakos Distinguished Alumni Award. He has received multiple teaching excellence awards for his classes on probability and statistical theory.

Ms. Kamerick is an expert in corporate governance, corporate finance, securities law, and mergers and acquisitions (M&A). She has held CFO positions at a number of prominent firms – including BP Amoco (Americas), Heidrick & Struggles, and Houlihan Lokey – and served as a senior financial and legal advisor to major multinational corporations. Ms. Kamerick is a former M&A and securities attorney with Skadden, Arps, Slate, Meagher & Flom. She has significant experience overseeing 401(k) and defined-benefit retirement plans, and chairing defined-benefit retirement plan investment committees. In addition to consulting on financial, strategic, and corporate governance matters, Ms. Kamerick serves on several boards, frequently acting as chair of the audit committee and as the board’s Securities and Exchange Commission (SEC) financial expert. She also serves on the boards of the Legg Mason Closed-End Mutual Funds and the AIG Funds & Anchor Series Trust (a mutual fund complex). Ms. Kamerick is a National Association of Corporate Directors (NACD) Board Leadership Fellow and holds the NACD Directorship certification. She has held several adjunct professorships and lectured on corporate governance and fiduciary duties at numerous universities, as well as in NACD’s Battlefield to Boardroom program for flag officers. Ms. Kamerick is a frequent contributor to Agenda and Directors & Boards. She serves on the Alzheimer’s Association board of directors, as well as its audit and finance committees. In 2020, she was a judge for IR Magazine’s Corporate Governance Awards.

Dr. Sosa specializes in the economics of network industries, law and economics, and industrial organization. He has consulted to telecommunications and electric utility clients on a broad range of litigation and regulatory issues, including industry restructuring, technical standardization, operational and financial benchmarking, mergers and acquisitions, market power analysis, and competitive strategy. Dr. Sosa has served as an expert witness before several state and federal agencies, and has supported testifying experts in assessing the economic impacts of several high-profile mergers in the telecommunications industry. In other telecommunications work, Dr. Sosa has analyzed spectrum license acquisitions, wireless technology standards, and voice and data roaming markets. He has also consulted to telecommunications carriers in Latin America, Europe, and Asia on issues related to competition, regulation, and litigation. In addition, Dr. Sosa has performed damages and valuation analyses for clients in a broad range of litigation matters, including consumer class actions, intellectual property, employment, bankruptcy, and commercial contracts. He is a frequent public speaker and has published a number of articles in industry and professional journals, including Public Utilities Fortnightly, the Journal of Legal Studies, and the Michigan Telecommunications and Technology Law Review. He is a member of the American Economic Association and Federal Communications Bar Association. Before joining Analysis Group, he consulted to the California Energy Commission and Telcordia. 

Professor Chandra focuses his research on innovation, productivity, and cost growth in health care; medical malpractice; and racial disparities in medical care. He has testified before the US Senate and the US Commission on Civil Rights and served as a special commissioner on the Massachusetts Special Commission on Provider Price Reform. Professor Chandra is a member of the Congressional Budget Office’s panel of health advisors, a research associate at the National Bureau of Economic Research, and an elected member of the American Academy of Arts and Sciences, the National Academy of Medicine, and the National Academy of Social Insurance. His research has been published in American Economic Review, the Journal of Political Economy, The Quarterly Journal of Economics, The New England Journal of Medicine, JAMA, Health Affairs, and other professional journals. Professor Chandra has received several awards for his work, including the Kenneth J. Arrow Award for best paper in health economics, the Garfield Award for outstanding research on the economic impact of medical and health research, the National Institute for Health Care Management Foundation Health Care Research Award, and the American Society of Health Economists’ ASHEcon Medal.

Dr. Siegel's research focuses on the management, strategy, and organizational issues related to cybersecurity, the intelligent integration of information systems, risk management, data analytics, state stability, systems modeling, security of energy delivery systems, and security researchers (aka hackers). He has served as an expert witness and filed expert reports in a number of IT-related litigations for clients such as SAP, JPMorgan, IBM, Kenexa, Fisher Scientific, Ernst & Young, and Macromedia. His expert case work includes matters involving the acquisition of a software firm, software patent litigation and review (e.g., the Patent Trial and Appeal Board case Versata v. SAP), patent infringement and validity analysis, software licensing agreement disputes, and matters involving financial services software and software related to the extraction of data from web pages. Dr. Siegel has published articles on such topics as simulation modeling for cyber resilience, cyber vulnerability markets, data management strategy, architecture for practical metadata integration, heterogeneous database systems, and managing and valuing a corporate IT portfolio using dynamic modeling of software development and maintenance processes. 

Mr. Ellman specializes in the application of microeconomics, statistics, and financial analysis to complex commercial litigation matters and government investigations. He has worked on behalf of the US Department of Justice and Federal Trade Commission, and has consulted to law firms in litigation and regulatory matters involving antitrust and competition, drug safety and product liability, intellectual property, data breaches, and general commercial damages issues. Mr. Ellman has conducted market analyses and assessments of competitive effects in major antitrust matters, as well as for proposed and executed mergers. He has also conducted statistical analysis, market research, and other economic analyses to evaluate the appropriateness of class certification in antitrust and commercial disputes, and to assess liability and damages. Mr. Ellman’s expertise in matters involving the pharmaceutical and medical device industries includes analyzing therapeutic markets and competitive dynamics; assessing evidence of causal associations in product liability suits; and conducting statistical analyses of market surveillance, clinical trial, and observational study data to evaluate the comparative effectiveness, safety, and dosing patterns of different treatments across a variety of therapeutic categories. He has published articles on a wide range of topics, including the assessment of causation and harm in data breach litigation, the appropriate analysis and interpretation of post-marketing surveillance data in product liability cases, and the economics of biosimilar drugs.

Professor Keller is a marketing expert who specializes in the application of consumer psychology, information processing, and choice behavior to complex litigation matters involving claims of consumer confusion, false advertising, trademark infringement, and product liability, among other topics. She studies the application of social marketing principles and behavioral theory in consumer and employee contexts, with a focus on designing and implementing consumer communication programs. Professor Keller’s research has been used to assess consumer behavior and decision making and address how consumers incorporate and respond to information across a variety of settings and industries, including pharmaceuticals, health care, financial services, consumer products, law, employee benefits, and insurance. She regularly collaborates with academic and industry experts to inform government-sponsored research on physician and patient decision making for organizations such as the National Institutes of Health, the National Cancer Institute, and the National Institute on Aging.

Professor Keller has consulted to firms on US Food and Drug Administration (FDA) and Federal Trade Commission (FTC) matters and worked on behalf of several government agencies, including the US Department of the Treasury and the Centers for Disease Control and Prevention (CDC). Her work has been published in several marketing journals, and she has also served on numerous journal editorial review boards. She has earned awards for designing effective communications related to health and savings from the Marketing Science Institute and the National Endowment for Financial Education, among others. Professor Keller’s research on decision making was cited by the Social and Behavioral Sciences Team’s 2015 Annual Report for the White House on the use of behavioral science in the design of federal programs and policies. Professor Keller is a fellow of the Association for Consumer Research.

A co-founder of Analysis Group, Inc., Dr. Stangle is an economist specializing in the fields of industrial organization and finance. He has over 40 years of experience directing large research projects in numerous industries on issues related to antitrust, regulation, bankruptcy, ERISA, and securities matters, and has consulted to firms on various management, strategy, and policy issues. Dr. Stangle has provided testimony on class certification, market definition, entry conditions, competitive effects, securities valuation, and damages. He is an outside member of the board of directors of Wellington Trust Company, NA, a money management firm, and a trustee emeritus of Bates College. Dr. Stangle also occasionally serves on the boards of startup firms, and was formerly a director of a mutual fund and a venture capital firm.

Read Bruce's profile

Professor Tucker is an industrial organization economist whose research spans the fields of technology, health care, real estate, and media and advertising. A particular focus of her work is on the role of data and digitization on competition and consumer behavior. Professor Tucker has deep experience as an expert witness in a variety of cases spanning antitrust and competition, intellectual property, data and data privacy, online advertising, and digital platforms. She has assessed market definition, competitive effects, liability, and class certification issues in matters involving pharmaceuticals, health insurance, consumer goods, sports and entertainment, energy, and consumer electronics, among other industries. She has testified about the effects of data, privacy, and algorithms before Congress, and has presented her work to agencies and organizations such as the Federal Trade Commission (FTC), the Federal Communications Commission (FCC), the International Monetary Fund (IMF), the European Commission Directorate-General for Competition (DG COMP), and the Australian Competition and Consumer Commission (ACCC).

Professor Tucker has published widely on innovation and technology diffusion; online advertising, customer heterogeneity, and algorithms; privacy regulation; network effects; and the economics of social networks. At the National Bureau of Economic Research (NBER), she serves as a research associate, focusing on privacy; a principal investigator on the Project on the Economics of Digitization; and a co-organizer of the Economics of Artificial Intelligence initiative, supported by the Alfred P. Sloan Foundation. Professor Tucker is a co-founder of the MIT Cryptoeconomics Lab, which studies digital currencies and blockchain, and chair of the MIT Sloan Ph.D. Program. Her articles have appeared in leading scientific, economic, management, and marketing journals. She has previously served as associate editor of Management Science and the Journal of Marketing Research and coeditor of Quantitative Marketing and Economics, and she is currently senior editor of Marketing Science.

Mr. Chen is an expert in structured finance with two decades of experience and product expertise in asset-backed securities and other structured products. These include collateralized debt obligations (CDOs), collateralized loan obligations (CLOs), derivative product companies (DPCs), asset-backed securities (ABS), residential mortgage-backed securities (RMBS), and structured investment vehicles (SIVs). Mr. Chen has served as a testifying expert on issues related to CLO, CDO, and RMBS ratings. He has provided management consulting and litigation support on securities and derivatives matters involving commercial and residential real estate, credit derivatives and total return swaps, and interest rate derivatives and indices, such as the London Interbank Offered Rate (LIBOR) and the transition from LIBOR to the secured overnight financing rate (SOFR). Prior to founding Pronetik in 2010, Mr. Chen was the chief operating officer (COO) and managing director at Centerline Financial LLC. There he monitored synthetic portfolios of multifamily and commercial real estate transactions, drafted and negotiated credit default swap documentation, and served as chief liaison with rating agencies. Earlier in his career, Mr. Chen was vice president of the structured finance-derivatives group at Moody’s Investors Service, where he rated transactions including cash flow and synthetic CDOs, structured notes, credit linked notes, and catastrophe (cat) bonds. He began his career as an associate at Willkie Farr & Gallagher, then joined Sullivan & Cromwell with a practice in corporate law, securities, and a concentration in structured finance. Mr. Chen has appeared on the CBS Evening News and been quoted or cited in media including The Wall Street Journal, Bloomberg News, and Businessweek.

Ms. Mulhern specializes in the application of economic principles to issues arising in complex business litigation. She has served as an expert witness on damages issues in commercial litigation matters, including intellectual property (IP) and breach of contract cases, providing testimony in various district and state courts. Ms. Mulhern’s intellectual property damages experience includes cases involving allegations of patent, copyright, and trademark infringement, as well as misappropriation of trade secrets; she has also provided expert testimony on these issues in Section 337 cases at the International Trade Commission (ITC). Before the ITC, she has testified on a variety of economic issues, such as domestic industry, remedy, bonding, commercial success, and public interest.  Ms. Mulhern’s litigation experience spans a variety of industries, including pharmaceuticals, medical devices, automotive, entertainment, consumer products, computer hardware and software, semiconductors, and telecommunications. In non-litigation matters, she has assisted clients in valuing intellectual property and other business assets in the context of strategic alliances and joint ventures. Ms. Mulhern has been recognized as among the top economic experts for IP matters by Intellectual Asset Management (IAM) in the IAM Patent 1000, which identifies leading patent professionals around the globe. She is a member of the American Economic Association and the Licensing Executives Society, and is a frequent writer and speaker on issues related to intellectual property valuation and damages assessment.

Mr. Fink specializes in the application of economic analyses to complex business litigation matters. He has provided expert support in a broad range of cases, including antitrust matters, intellectual property (IP) cases, general business litigation, and regulatory proceedings. Mr. Fink has experience supporting experts across a variety of industries, including pharmaceuticals, high tech, agriculture, and media and entertainment. His case work has included antitrust claims against brand and generic drug manufacturers involving allegations of reverse-payment settlements, IP disputes involving biologic and biosimilar pharmaceutical manufacturers, and restraint of trade allegations involving exclusive licensing in the cosmetics industry. He has assisted attorneys, academic affiliates, and industry experts in all phases of complex litigation, including pretrial discovery, case strategy, expert reports, deposition support, and trial preparation.

Professor Kiesling is an expert in energy and regulatory economics, energy history, energy market design, and technology in the development of energy markets, with a particular interest in the electricity industry. Her research focuses on electricity policy and market design issues related to regulation and technological change; the economics of smart grid technologies; and the interaction of market design and innovation in the development of retail energy markets, products, and services. Professor Kiesling has provided expert testimony in proceedings before the Federal Energy Regulatory Commission (FERC), the California Public Utilities Commission, the Illinois Commerce Commission, and the New York Public Service Commission. She teaches at economics workshops for regulators, and lectures to academic, industrial, and regulatory groups about regulatory policy, institutional change, and the economic analysis of electric power market design. Professor Kiesling is the author of two books and numerous articles, book chapters, policy studies, and public interest comments. She serves on the Electricity Advisory Committee for the US Department of Energy, as well as the Academic Advisory Council for the UK Institute of Economic Affairs. Previously, Professor Kiesling was a visiting associate professor at Carnegie Mellon University and held positions in the economics departments of Purdue University and Northwestern University.

Mr. Starfield specializes in the direction and management of large-scale cases involving complex economic and financial issues. For more than two decades, he has conducted economic analysis and managed case teams in support of leading academic experts in a range of cases, notably a number of matters involving complex securities, including residential mortgage-backed securities, collateralized debt obligations, and credit default swaps. In matters related to the Lehman bankruptcy, he supported multiple experts in assignments related to structured financial products, secured financing, collateral management, derivatives risk exposure, complex accounting topics, and the causes of Lehman's failure. He also managed case teams in the Enron-related litigations involving some of the major settlements emerging from the Enron bankruptcy. In addition, he has worked on a broad range of cases in the investment management area, including numerous matters involving alleged violations of Sections 10b-5 and 11, in which he provided management of many dimensions of financial and economic analysis, including market efficiency, loss causation and materiality, and damages. Mr. Starfield also worked with mutual fund companies, boards, and regulators in some of the most prominent market timing matters. He managed all aspects of financial and economic analysis in a fraudulent conveyance litigation involving one of the largest bank failures in US history, including identification and support of numerous academic expert witnesses who testified on the economics of the banking industry; conditions in real estate markets; the management, operation, and regulation of nationally chartered commercial banks and bank holding companies; and factors that led to bank failures.

He has conducted analyses and served as an expert in numerous matters involving commercial disputes, and also has significant experience in the valuation of large, closely held companies.

In his role as an expert, Mr. Starfield has developed economic and financial models; prepared testimony; developed, presented, and reviewed pretrial discovery; and evaluated the economic and financial analyses of opposing experts. He has provided support to successful testimony on numerous topics involving economics in both bench and jury trials. Outside of litigation, he has assisted clients in a variety of industries with development of business plans and financial projections, frequently involving the use of complex integrated financial models. Formerly a senior manager in the Dispute Analysis and Corporate Recovery Services group of Price Waterhouse, Mr. Starfield is a chartered accountant of South Africa, a member of the South African Institute of Chartered Accountants, and a member of the Association of Chartered Certified Accountants in the United Kingdom.

Professor Skrzypacz is an expert in industrial organization and market design. His research centers on microeconomic theory and its applications, including collusion, auctions, pricing, and bargaining. In addition to his academic research, Professor Skrzypacz consults on auction strategy and competition issues, and has served as an academic visitor at Yahoo! Research. He has counseled bidders in wireless spectrum auctions in the United States, Canada, the Netherlands, Switzerland, Austria, and Sweden. He has also advised internet companies on design and competition in online auctions, and communication companies on regulation issues.

Professor Skrzypacz has published a number of articles on topics such as using spectrum auctions to enhance competition in wireless services, private monitoring and communication in cartels, and information disclosure. His most recent papers have focused on auction design, dynamic games, and collusion in markets. He is an associate editor of The RAND Journal of Economics and American Economic Review: Insights, and a former coeditor of American Economic Review. Additionally, Professor Skrzypacz is a fellow of the Econometric Society, an economic theory fellow of the Society for the Advancement of Economic Theory, and a senior fellow of the Rimini Centre for Economic Analysis.

Professor Tufano’s work spans a broad range of topics in finance, including climate finance and derivatives and structured finance. His research interests include financial innovation, business solutions to climate change, the design of new securities and financial instruments, the organization of financial markets, corporate risk management, the mutual fund industry, and household finance. Professor Tufano has provided expert testimony and reports in several finance- and securities-related matters, including a matter involving retained asset accounts; the Parmalat securities litigation; economic characterizations of securities for tax courts; and the Enron Corporation securities, derivative, and ERISA litigations.

He has written a number of books, and his articles have been published in journals such as The Journal of Finance, the Journal of Financial Economics, The Review of Financial Studies, and Harvard Business Review. He is an associate editor of the Journal of Investment Management. Professor Tufano’s work has also been featured in a number of media outlets, including The New York Times and the Financial Times. He has received several awards, including the Smith Breeden Prize for the best finance paper published in The Journal of Finance and a leadership award from the Aspen Institute. Prior to re-joining the Harvard Business School faculty, he was dean of the Saïd Business School at the University of Oxford for a decade.

Ms. Okie has conducted economic and financial analyses and managed case teams in support of academic and industry experts across engagements in securities and antitrust litigation, regulatory investigations, bankruptcy matters, arbitrations, and general commercial litigation. Her experience spans a wide variety of sectors and has included fact and expert discovery, class certification, liability and damages, and trial. Her antitrust work includes civil and criminal litigation surrounding a variety of alleged anticompetitive conduct and analyses of competition issues across a range of industries. Ms. Okie has worked on a number of matters at the intersection of antitrust and financial services, including alleged anticompetitive conduct related to foreign exchange rates, municipal bond markets, and financial product trading. She has assessed alleged misrepresentations and omissions in the underwriting of securities, including issues surrounding loss causation, falsity, materiality, and buy-side and sell-side due diligence; analyzed valuation issues in mergers and acquisitions; and evaluated REIT market corporate governance and industry dynamics. In the energy sector, Ms. Okie has estimated damages associated with failed projects; valued rights-of-way; and supported clients involved in market manipulation investigations by the US Department of Justice (DOJ), the Commodity Futures Trading Commission (CFTC), the Federal Energy Regulatory Commission (FERC), and state agencies. She has evaluated trading data, market power, and other competitive issues in oil, natural gas, propane, and electricity markets. Ms. Okie has published on many energy; environmental; and environmental, social, and governance (ESG) topics and authored white papers and reports for foundations, regional transmission organizations, and industry organizations. Ms. Okie is vice-chair of the Insurance and Financial Services Committee of the American Bar Association’s Antitrust Law Section.

Mr. Contino specializes in the analysis and valuation of residential mortgage loans and securities, to both market participants and in complex litigation. His expertise extends to the valuation of niche security and loan products (e.g. residuals, resecuritizations, SF rental securities, timeshares, second liens). Clients have included broker-dealers, other investment advisors, bankruptcy experts, REITs, insurance companies, pension funds, and US government-sponsored enterprises, among others. Other government experience includes providing quantitative support to a sale advisor to the US Department of Housing and Urban Development, the Small Business Administration, and the Federal Deposit Insurance Corporation. He provided similar support during the development of the Mortgage Purchase Program for the Federal Home Loan Banks of Cincinnati, Indianapolis, and Seattle. Mr. Contino took two leaves of absence from Sperlinga Advisory to serve as a mortgage hedge fund portfolio manager, with one of those roles overlapping the mortgage market crisis.

As a testifying expert, Mr. Contino has written reports and provided testimony in arbitration as well as in both federal and state court. He served as a consulting expert in a series of cases for the US Department of Labor – Office of the Solicitor, involving mortgage securities and ERISA. His litigation-related experience spans the residential mortgage industry, with disputes involving valuation, suitability, market practices, and intellectual property. The valuation cases have included the spectrum of mortgage loan credit (agency, prime, Alt-A, subprime) and the spectrum of securitization structures (senior and subordinate securities, complex resecuritizations, residuals, and both performing and non-performing whole loans).

Professor LaRue has been recognized as an expert in federal and international taxation, financial and cost accounting, and economic and financial analysis in several cases before the US Tax Court, US District Courts, and the US Court of Federal Claims. He has provided invited testimony on tax policy issues before the US House of Representatives Ways and Means Committee and the US Department of the Treasury. As a faculty member at the University of Virginia for 25 years, Professor LaRue taught undergraduate and graduate courses on financial accounting, federal taxation, economic analysis, and international finance and business at the McIntire School of Commerce, and served as the director of its graduate accounting program. He also developed and taught in-house continuing education courses on federal taxation for KPMG; PwC; Ernst & Young; Deloitte Touche; and the NYU School of Law in connection with the Internal Revenue Service’s (IRS’s) Office of Chief Counsel; among others. Professor LaRue has authored articles on various aspects of taxation that have appeared in publications including NYU’s Tax Law Review and the American Bar Association’s The Tax Lawyer. He has chaired and served on committees and task forces for numerous organizations, including the Tax Section of the American Institute of Certified Public Accountants (AICPA), the American Taxation Association, the American Accounting Association, and others. In recognition for his work as an instructor, researcher, and expert, Professor LaRue has won over a dozen teaching awards, including the Virginia Society of Certified Public Accountants’ Outstanding Educator Award and the Ernst & Young Tax Literature Award, as well as commendations from both the US Department of Justice’s Fraud Section and the Criminal Investigation Division of the IRS.

Professor Snow is an expert in technology and operations, innovation management, and service management, with a specialization in automotive, health care, aerospace, and growth-stage companies. His research addresses two areas: the complex relationship between new and old technologies during technology transitions; and service operations, particularly the building of theoretical microfoundations to help define the field, and empirical research on operational productivity. Professor Snow has testified in antitrust and competition cases as well as commercial disputes. He has taught at Harvard Business School, The Wharton School of the University of Pennsylvania, Tuck School of Business at Dartmouth College, and BYU Marriott School of Business; presented at a variety of management, innovation, and technology conferences; and written numerous cases for academic use. In 2014, he and coauthor Lamar Pierce received the Olin Award for Research That Transforms Business. Professor Snow is an executive committee member of the Harvard Business School Institutions and Innovation Conference, and a former board member of the Council of Supply Chain Management Professionals.

Mr. Gold has more than 20 years of experience applying economics, finance, and statistics to litigation matters. He has been involved in all phases of the litigation process, from pretrial discovery to expert report and trial preparation. Mr. Gold has led teams supporting experts and assisted counsel on a variety of securities, commercial litigation, and intellectual property matters.

Mr. Gold has extensive experience consulting on securities matters, including analyzing market efficiency, estimating damages, conducting event studies, and analyzing potential settlements. He has also submitted expert declarations in civil and criminal securities fraud matters. His experience includes cases involving securities and financial derivatives such as swaps, structured notes, mortgage-backed securities, convertible preferred stock, and options. Mr. Gold has worked on antitrust matters involving the trading of securities, and he has conducted assessments of class certification in cases involving securities fraud, product liability, and false advertising, including analyzing whether liability or damages can be assessed using common proof. His work spans industries such as financial services, legal services, telecommunications, entertainment, health care, and oil and gas. He is the coauthor of “Federal Securities Acts and Areas of Expert Analysis” in the Litigation Services Handbook.

Professor Lambrecht is an expert in digital marketing and consumer behavior. Her research focuses on marketing decisions in digital environments – emphasizing online targeting, advertising, promotion, and pricing. In the context of digital marketing, Professor Lambrecht has examined how firms can use retargeting to reach out to consumers; how firms can advertise on Twitter to early trend propagators; the role of position effects on information displayed to consumers online; and, more broadly, the value of big data for firms. In her online pricing work, Professor Lambrecht examines the economics of pricing online services and online promotions, such as daily deals or cashback promotions.

Recently published research explores the role of economics in the context of apparent algorithmic biases. Currently, Professor Lambrecht is studying the value of top positions in organic search results and how users contribute to crowdfunding campaigns. In an additional research stream on price discrimination in service industries, she has focused on the use of multi-part tariffs by service providers such as telecom companies.

Professor Lambrecht has published a number of articles in leading academic journals, such as Marketing Science, Management Science, and the Journal of Marketing Research. Among other awards, she has received the American Marketing Association's Paul E. Green Award and has recently been selected as the winner of the prestigious William F. O'Dell Award. In addition, Professor Lambrecht has held several editorial roles at prominent academic publications.

Dr. Strombom is an expert in applied microeconomics, finance, and quantitative and statistical analysis. He provides assistance to attorneys in all phases of pretrial and trial practice, prepares economic and financial models, and provides expert testimony in litigation and public policy matters. Dr. Strombom has conducted assessments of class certification, liability, and damages issues in cases involving antitrust, breach of contract, ERISA, false advertising, intellectual property, labor and employment, product liability, securities, and general commercial disputes.

Prior to joining Analysis Group, Dr. Strombom was Executive Vice President of a middle-market merger and acquisition firm, where he managed a financial and market research organization that provided valuation and consulting services to over 500 privately held companies annually. Previously, he was Consulting Manager at Price Waterhouse, where he provided litigation support and value enhancement consulting services, and Senior Financial Analyst at the Tribune Company, where he evaluated capital projects and acquisition candidates.

Professor Srinivasan focuses his research in the areas of marketing, advertising, e-commerce, technology, and innovation. He specializes in applying structured economic models to unstructured data by merging the tools of econometrics and data science (including machine learning techniques). Specific topics he has consulted and published on include the sharing economy, competitive dynamics and pricing in two-sided platforms; machine learning algorithms and their inherent biases; and health outcomes data. Professor Srinivasan has consulted to several Fortune 500 companies. He has founded two startups and served on the boards of both startups and a private equity firm. He has served on the editorial boards of the Journal of Marketing Research, Management Science, Marketing Science, and Quantitative Marketing and Economics. He was a coeditor-in-chief of the Marketing Science special issue on emerging markets. Professor Srinivasan is a former president of the INFORMS Society for Marketing Science. He has been granted several patents on dynamic business models on the internet and has worked closely with patent examiners. His patents have been licensed by a Fortune 3 firm, and he has a deep knowledge of the securing and infringement of patents.

Arnold Barnett's research specialty is applied mathematical modeling generally focused on problems of health and safety. His early work on homicide was presented to President Ford at the White House, and his analysis of US casualties in Vietnam was, among other things, the subject of a column by William F. Buckley. He has received the President's Award and the Expository Writing Award from INFORMS (1996 and 2001, respectively) and the President's Citation from the Flight Safety Foundation (2002) for “truly outstanding contributions on behalf of safety.” He has written op-ed pieces for The New York Times, The Wall Street Journal, The Boston Globe, and USA Today. Ten times he has been honored for outstanding teaching by students at MIT's Sloan School of Management; in 1992, Business Week described him as the “best” Sloan School faculty member. Dr. Barnett has testified in many legal proceedings as a statistical expert and an aviation-safety expert.

Mr. Conway is an expert on complex technical accounting, Sarbanes-Oxley compliance, and corporate governance, with 40 years of experience in public accounting. His litigation experience includes preparing expert witness reports, assisting counsel with case strategy, and testimony. Prior to his consulting career, Mr. Conway was the regional associate director of the Public Company Accounting Oversight Board (PCAOB) in Orange County and Los Angeles. At the PCAOB, he inspected audits of the Big Four firms, focusing on revenue recognition, business combination accounting, the valuation of identifiable intangible assets, and impairment testing of goodwill and identifiable intangibles. Mr. Conway has also been the senior professional practice director at CNM, a technical accounting advisory firm, and an audit partner at KPMG, where he served for 26 years. He is the author of The Truth About Public Accounting: Understanding and Managing the Risks the Auditors Bring to the Audit, and he has led a number of corporate seminars on accounting and auditing issues, including at the Stanford Graduate School of Business.

Ms. Pike applies her expertise in health economics, statistics, and large administrative claims and transaction-level databases to help resolve complex litigation and strategic business questions in a variety of contexts, including matters involving the False Claims Act, Anti-Kickback Statute, and Controlled Substance Act. She has performed economic analyses and presented findings to US Attorney's Office investigators in numerous cases involving allegations of off-label promotion, kickback, and pricing issues. Ms. Pike also applies economic theory and empirical estimation methods in a variety of product liability, breach of contract, intellectual property, and transfer-pricing engagements. She has extensive experience in developing flexible damages models for real-time use in high-stakes negotiations. 

Ms. Pike has been instrumental in developing bespoke suspicious order monitoring programs; building internal analytical programs to assess the risk of theft or diversion; and assisting manufacturers, wholesalers, and pharmacies in responding to government investigations and/or lawsuits related to controlled substance distribution and dispensing. She has managed a range of health care cases involving analysis of future lost profits; economic analysis of physician payment structures under capitation; studies of the cost effectiveness, budget impacts, and direct and indirect costs of illness associated with a variety of diseases; and pricing analyses for large multinational corporations across numerous industries. Ms. Pike has published numerous articles on related topics in health care economics and clinical journals.

Mr. Gorin has more than 30 years of experience as a strategy and economic consultant with deep expertise in the health care, chemicals, oil and gas, agriculture, and automotive industries. He leads large, complex engagements in antitrust matters, health care strategy, and large commercial litigation cases, providing direct leadership at every stage of engagement, from strategy to implementation. In addition to his own expert work, Mr. Gorin regularly identifies and collaborates with leading academic and industry affiliates. Mr. Gorin's unique experience across industries and practices allows him to leverage his complementary strategic, economic, and specific subject matter expertise to provide pragmatic solutions to address clients' complex business and legal challenges. 

Mr. Gorin's work in antitrust and competition cases has included the analysis of alleged anticompetitive behavior and the evaluation of the competitive impact of mergers and acquisitions in strategic, regulatory, and litigation contexts. In these cases, Mr. Gorin has defined and analyzed relevant markets, assessed potential or past competitive impact, simulated the outcome of mergers and acquisitions in the marketplace, and evaluated potential antitrust remedies. As a leading expert in Analysis Group's Health Care Strategy practice, Mr. Gorin works with diagnostic innovators and manufacturers to develop acquisition and growth strategies, create plans to achieve favorable coverage and reimbursement in the United States and international markets, and design and implement evidence development strategies to support coverage and reimbursement goals. In commercial litigation cases, he regularly leads teams and experts to support clients in matters related to liability and damages, such as valuation, economic harm, accounting, corporate governance, and organizational performance and culture. 

Prior to joining Analysis Group, Mr. Gorin was a partner in the worldwide Energy, Chemicals, and Pharmaceuticals Group at Booz, Allen & Hamilton, Inc.

Professor Mayzlin’s research focuses on how businesses manage social interactions, advertising, and communication strategies, including word of mouth and social media. She has filed expert reports and testified at deposition in marketing-related litigation matters, including testimony in a lawsuit involving the way a major e-commerce company aggregated product reviews. In another case, she analyzed allegations that the plaintiff’s competitor had posted fake negative reviews on its Yelp page. Professor Mayzlin has written numerous scholarly articles on social media management, the manipulation of online reviews, measuring online word of mouth, and online influencers. She is also an associate editor at Marketing Science. Her work has earned several awards, including the INFORMS Society for Marketing Science Long Term Impact Award, and been cited more than 15,000 times on Google Scholar. A frequent speaker, Professor Mayzlin has provided keynote addresses at academic conferences worldwide, including the Advertising and Consumer Psychology Conference and the Interactive Marketing Research Conference. She has co-chaired and presented at the Summer Institute in Competitive Strategy at the Haas School of Business at the University of California, Berkeley. Prior to joining the USC Marshall School, where she teaches undergraduate, M.B.A., and doctoral courses, Professor Mayzlin served on the faculty of the Yale School of Management.

Mr. Lawrence is an expert in due diligence, investment practices, and corporate governance. He has testified and been retained as an expert in high-profile securities lawsuits and advised the US Securities and Exchange Commission (SEC) on due diligence and investment practices. In his role at Pacific Financial Group, Mr. Lawrence oversees a portfolio of private equity, marketable securities, and alternative investments. He teaches due diligence at Southern Methodist University, where he founded the Center for Advanced Due Diligence Studies. Mr. Lawrence has published extensively in the field and is the author of Due Diligence in Business Transactions, a leading text in the field for more than 20 years; Due Diligence: Investigation, Reliance & Verification – Cases, Guidance and Contexts; Due Diligence: Law, Standards and Practice; and Due Diligence, a Scholarly Study. His work has been cited by the US District Court for the Southern District of New York, in filings before the US Supreme Court, and in other publications. He has served on boards of directors and on the audit, management, compensation, and executive committees of public and private companies. Prior to his academic and investment career, Mr. Lawrence was a managing partner of an international law firm, where he founded and taught the firm’s due diligence training program, managed its investment fund, and chaired the global technology, media, and telecommunications practice. He has been admitted to the state bars of New York, the District of Columbia, and Texas.